Spontaneous bacterial peritonitis: Difference between revisions
From IDWiki
(Imported from text file) |
mNo edit summary |
||
| (10 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | ==Background== |
||
| − | = Spontaneous bacterial peritonitis (SBP) = |
||
| + | *Primary infection of the ascitic fluid, diagnosed by ascites fluid with positive culture or with neutrophil count greater than 250 |
||
| − | == Definition == |
||
| + | ===Microbiology=== |
||
| − | * Primary infection of the ascitic fluid |
||
| + | *''[[Escherichia coli]]'' (43%) |
||
| − | == Pathophysiology == |
||
| + | *''[[Klebsiella pneumoniae]]'' (11%) |
||
| + | *''[[Streptococcus pneumoniae]]'' (9%), particularly affecting people with [[HIV]] and prepubertal girls |
||
| + | *Other streptococcal species (19%) |
||
| + | *Enterobacteriaceae (4%) |
||
| + | *''[[Staphylococcus]]'' (3%) |
||
| + | *''[[Pseudomonas]]'' (1%) |
||
| + | *Miscellaneous (10%) |
||
| + | **''[[Aeromonas hydrophila]]'', in Korea |
||
| + | **[[Peritoneal tuberculosis]] |
||
| + | **[[Dimorphic fungi]] |
||
| + | ===Pathophysiology=== |
||
| − | * Intestinal bacterial overgrowth with increased intestinal permeability leads to translocation to intestinal lymph notes and bloodstream, which results in hematogenous seeding to ascitic fluid |
||
| − | * Only occurs in portal hypertension, not in other causes of ascites |
||
| + | *Intestinal bacterial overgrowth with increased intestinal permeability leads to translocation to intestinal lymph notes and bloodstream, which results in hematogenous seeding to ascitic fluid |
||
| − | == Bacteriology == |
||
| + | *Only occurs in portal hypertension, not in other causes of ascites |
||
| + | ===Risk Factors=== |
||
| − | * ''Escherichia coli'' (43%) |
||
| − | * ''Klebsiella pneumoniae'' (11%) |
||
| − | * ''Streptococcus pneumoniae'' (9%) |
||
| − | * Other streptococcal species (19%) |
||
| − | * Enterobacteriaceae (4%) |
||
| − | * ''Staphylococcus'' (3%) |
||
| − | * ''Pseudomonas'' (1%) |
||
| − | * Miscellaneous (10%) |
||
| − | ** ''Aeromonas hydrophila'', in Korean |
||
| + | *Previous history of SBP |
||
| − | == Risk Factors == |
||
| + | *[[Upper GI bleed]] |
||
| + | *Low sciatic protein |
||
| + | *Child-Pugh class |
||
| + | ==Clinical Manifestations== |
||
| − | * Previous history of SBP |
||
| − | * Upper GI bleed |
||
| − | * Low sciatic protein |
||
| − | * Child-Pugh class |
||
| + | *Asymptomatic in 10% |
||
| − | == Presentation == |
||
| + | *Fever (70%) |
||
| + | *Abdominal pain (60%) |
||
| + | *Hepatic encephalopathy (50%) |
||
| + | *Abdominal tenderness, usually without rigidity (50%) |
||
| + | *Diarrhea (30%) |
||
| + | *Ileus (30%) |
||
| + | *Shock (20%) |
||
| + | *Hypothermia (15%) |
||
| + | ===Variants=== |
||
| − | * Asymptomatic in 10% |
||
| − | * Fever (70%) |
||
| − | * Abdominal pain (60%) |
||
| − | * Hepatic encephalopathy (50%) |
||
| − | * Abdominal tenderness, usually without rigidity (50%) |
||
| − | * Diarrhea (30%) |
||
| − | * Ileus (30%) |
||
| − | * Shock (20%) |
||
| − | * Hypothermia (15%) |
||
| + | *'''Culture-negative neutrocytic ascites:''' usually caused by difficult-to-treat organisms like tuberculosis, and non-infective sources |
||
| − | == Investigations == |
||
| + | *'''Monomicrobial non-neutrocytic bacterascites:''' early bacterial colonization |
||
| + | *'''Polymicrobial bacterascites:''' usually from traumatic paracentesis |
||
| + | ===Prognosis and Complications=== |
||
| − | * Labs |
||
| − | ** Ascitic fluid for cell count and culture |
||
| − | *** Neutrophil count < 250 rules it out |
||
| − | *** Culture usually monomicrobial |
||
| − | ** Repeat paracentesis at 48h if ongoing concern |
||
| − | * Imaging |
||
| − | * Other |
||
| + | *In-hospital mortality of about 33% in hospital |
||
| − | == Management == |
||
| + | *58% 6-month mortality |
||
| + | ==Investigations== |
||
| − | * Acute |
||
| − | ** Ceftriaxone 1-2g IV q24h |
||
| − | * Chronic |
||
| − | ** Prophylaxis after a single episode |
||
| − | *** Septra SS PO daily |
||
| − | *** Norfloxacin |
||
| − | * Some role for primary prophylaxis, I think? |
||
| + | *Diagnostic paracentesis with ascitic fluid sent for cell count with differential and culture |
||
| − | == Prognosis == |
||
| + | **Neutrophil count < 250 rules it out |
||
| + | **Culture usually monomicrobial |
||
| + | *Repeat paracentesis at 48h if ongoing concern |
||
| + | ==Management== |
||
| − | * In-hospital mortality of about 33% in hospital |
||
| − | * 58% 6-month mortality |
||
| + | *[[Is treated by::Ceftriaxone]] 1-2g IV q24h + [[albumin]] 1.5 g/kg on day 1 and 1 g/kg on day 3 |
||
| − | == Further Reading == |
||
| + | |||
| + | ==Prevention== |
||
| + | |||
| + | *Prophylaxis is indicated after even a single episode of SBP |
||
| + | **[[TMP-SMX]] SS or DS PO daily |
||
| + | **[[Norfloxacin]] 400 mg PO daily |
||
| + | **[[Ciprofloxacin]] 500 mg PO daily |
||
| + | **[[Doxycycline]] 100 mg PO daily is under investigations as an alternative[[CiteRef::nguyen2023do]] (see [https://aasld.confex.com/aasld/2020/meetingapp.cgi/Paper/19190 abstract]) |
||
| + | *Possibly a role for primary prophylaxis |
||
| + | |||
| + | [[Category:Intra-abdominal infections]] |
||
Latest revision as of 14:08, 19 September 2024
Background
- Primary infection of the ascitic fluid, diagnosed by ascites fluid with positive culture or with neutrophil count greater than 250
Microbiology
- Escherichia coli (43%)
- Klebsiella pneumoniae (11%)
- Streptococcus pneumoniae (9%), particularly affecting people with HIV and prepubertal girls
- Other streptococcal species (19%)
- Enterobacteriaceae (4%)
- Staphylococcus (3%)
- Pseudomonas (1%)
- Miscellaneous (10%)
Pathophysiology
- Intestinal bacterial overgrowth with increased intestinal permeability leads to translocation to intestinal lymph notes and bloodstream, which results in hematogenous seeding to ascitic fluid
- Only occurs in portal hypertension, not in other causes of ascites
Risk Factors
- Previous history of SBP
- Upper GI bleed
- Low sciatic protein
- Child-Pugh class
Clinical Manifestations
- Asymptomatic in 10%
- Fever (70%)
- Abdominal pain (60%)
- Hepatic encephalopathy (50%)
- Abdominal tenderness, usually without rigidity (50%)
- Diarrhea (30%)
- Ileus (30%)
- Shock (20%)
- Hypothermia (15%)
Variants
- Culture-negative neutrocytic ascites: usually caused by difficult-to-treat organisms like tuberculosis, and non-infective sources
- Monomicrobial non-neutrocytic bacterascites: early bacterial colonization
- Polymicrobial bacterascites: usually from traumatic paracentesis
Prognosis and Complications
- In-hospital mortality of about 33% in hospital
- 58% 6-month mortality
Investigations
- Diagnostic paracentesis with ascitic fluid sent for cell count with differential and culture
- Neutrophil count < 250 rules it out
- Culture usually monomicrobial
- Repeat paracentesis at 48h if ongoing concern
Management
- Ceftriaxone 1-2g IV q24h + albumin 1.5 g/kg on day 1 and 1 g/kg on day 3
Prevention
- Prophylaxis is indicated after even a single episode of SBP
- TMP-SMX SS or DS PO daily
- Norfloxacin 400 mg PO daily
- Ciprofloxacin 500 mg PO daily
- Doxycycline 100 mg PO daily is under investigations as an alternative1 (see abstract)
- Possibly a role for primary prophylaxis
References
- ^ Ngoc Nguyen, Matthew Crotty, Edward A. Dominguez, Adil Habib, Hector E. Nazario, Zahid M. Vahora, Parvez S. Mantry, Jessiva Rago, Melanie Proffitt, Maisha N. Barnes, Ashwini Mehta, Mangesh R. Pagadala, Jeffrey S. Weinstein. Doxycycline for the prevention of spontaneous bacterial peritonitis. The Liver Meeting. 2023.
